Search Results Search Sort by RelevanceMost Recent Policy Forum Jul 2009 Patents, Pricing, and Access to Essential Medicines in Developing Countries Brook K. Baker, JD A major contributor to the lack of medicines in developing countries is an intellectual property regime that allows proprietary drug companies with intellectual property monopolies to charge high prices and maximize profit. Virtual Mentor. 2009;11(7):527-532. doi: 10.1001/virtualmentor.2009.11.7.pfor1-0907. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. Medicine and Society Jun 2001 Feeding Health Disparities Kayhan Parsi, JD, PhD and Sara Taub, MA Virtual Mentor. 2001;3(6):191-193. doi: 10.1001/virtualmentor.2001.3.6.puhl1-0106. Case and Commentary Feb 2021 通过避免判断主义和情境化护理来促进卫生公平性 Saul J. Weiner (医学博士) AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91. Case and Commentary Feb 2021 Fomento de la equidad en salud a través de un enfoque que evite los juicios de valor y contextualice la atención Saul J. Weiner, MD AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91. Case and Commentary Feb 2021 临床医生应如何应对会加剧卫生不平等性的语言障碍? Jason Espinoza(医学博士) and Sabrina , Derrington(医学博士、文学硕士、已获认证的医疗保健伦理顾问) AMA J Ethics. 2021;E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 ¿Cómo deberían responder los médicos clínicos a las barreras idiomáticas que exacerban la inequidad sanitaria? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C AMA J Ethics. 2021;E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. Pagination First page « First Previous page ‹ Previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page Next › Last page Last »
Policy Forum Jul 2009 Patents, Pricing, and Access to Essential Medicines in Developing Countries Brook K. Baker, JD A major contributor to the lack of medicines in developing countries is an intellectual property regime that allows proprietary drug companies with intellectual property monopolies to charge high prices and maximize profit. Virtual Mentor. 2009;11(7):527-532. doi: 10.1001/virtualmentor.2009.11.7.pfor1-0907.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
Medicine and Society Jun 2001 Feeding Health Disparities Kayhan Parsi, JD, PhD and Sara Taub, MA Virtual Mentor. 2001;3(6):191-193. doi: 10.1001/virtualmentor.2001.3.6.puhl1-0106.
Case and Commentary Feb 2021 通过避免判断主义和情境化护理来促进卫生公平性 Saul J. Weiner (医学博士) AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91.
Case and Commentary Feb 2021 Fomento de la equidad en salud a través de un enfoque que evite los juicios de valor y contextualice la atención Saul J. Weiner, MD AMA J Ethics. 2021;E91-96. doi: 10.1001/amajethics.2021.91.
Case and Commentary Feb 2021 临床医生应如何应对会加剧卫生不平等性的语言障碍? Jason Espinoza(医学博士) and Sabrina , Derrington(医学博士、文学硕士、已获认证的医疗保健伦理顾问) AMA J Ethics. 2021;E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 ¿Cómo deberían responder los médicos clínicos a las barreras idiomáticas que exacerban la inequidad sanitaria? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C AMA J Ethics. 2021;E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020;22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.